Sunridge International to Present to the Long Island Investment Banking Group

FOUNTAIN HILLS, Ariz., Feb. 22 /PRNewswire-FirstCall/ -- Sunridge International, (OTC Bulletin Board: SNDZ) announced that it will be making a presentation today to the Long Island Investment Banking Group, comprised of over 73 of the top brokerage firms in the Long Island area.

In its presentation, Sunridge International (www.sunridgeint.com) intends to communicate progress achieved in developing its business model as well as the significant progress made throughout the European market, and to inform attendees of the abundant market opportunity.  Sunridge will be seeking to increase market awareness, initiate research coverage, add market makers, and attract both institutional and retail investors to its publicly traded stock.

About LIIBG

The LIIBG was founded in 1996 by brokers to serve brokers and publicly traded companies. We are the strongest investment banking group in the tri-state area focusing on small cap/micro cap companies. Our monthly meeting is well attended by licensed, active brokers comprising an average of two billion dollars under management.

About Sunridge International

Sunridge, through it's wholly owned subsidiary Ophthalmic International, has developed and patented Pneumatic Trabeculoplasty, "PNT", a two-minute, non-evasive, cost effective alternative treatment for Glaucoma and Ocular Hypertension.

Glaucoma is the second leading cause of blindness, effecting over 70 million people worldwide. PNT has been proven (through studies completed over the last 10 yrs) to be a safe and effective treatment with no adverse side effects associated with it, unlike typical forms of glaucoma treatment.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.  Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission.

SOURCE Sunridge International